Low-dose rivaroxaban plus antiplatelet therapy for symptomatic intracranial atherosclerotic stenosis: A prospective cohort study
DPI therapy may be associated with a lower risk of recurrent stroke compared with antiplatelet therapy alone in patients with sICAS. These findings warrant further investigation through large-scale randomized controlled trials.
Authors
- W Zhang
- Lan C
- Haiman Hou
- Jiaxin Wang (ORCID: https://orcid.org/0000-0001-9007-2259)
- F. S. Buonanno
- Lulu X Pei (ORCID: https://orcid.org/0000-0002-1168-7990)
- Kun Liu (ORCID: https://orcid.org/0000-0001-5807-0501)
- Yifang Zhou (ORCID: https://orcid.org/0000-0002-3245-212X)
- Yige Zhang (ORCID: https://orcid.org/0000-0001-6213-1899)
- Xinsheng Han (ORCID: https://orcid.org/0000-0003-1772-6652)
- Zhaoyang Zhao (ORCID: https://orcid.org/0000-0002-8962-3161)
- MingMing Ning
- Yiwei Qian
- Y. Xu
- Xinyi Leng
- Yuesong Pan
- Yuan Cao
- Ding Zhang
- Bo Song
- Wenzheng Rong
- Ce Zong
Institutions
- Harvard University (US)
- Chinese University of Hong Kong (HK)
- Capital Medical University (CN)
- Liverpool School of Tropical Medicine (GB)
- Zhengzhou University (CN)
- Beijing Tian Tan Hospital (CN)
- Massachusetts General Hospital (US)
- Xian Central Hospital (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- International Journal of Stroke
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1177/17474930261423387
- Primary Topic
- Cerebrovascular and Carotid Artery Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00